688P - Prognostic impact of KRAS mutation in metastatic (met) pancreatic cancer patients (pts)

Autor: Verdaguer, H. 1, Sauri, T. 1, Ruiz, F. 2, Vivancos, A. 3, Nuciforo, P. 4, Capdevila, J. 1, Elez, E. 1, Alsina, M. 1, Martinez, G. Argiles 1, Hierro, C. 1, Grasselli, J. 1, Matos, I. 1, Tabernero, J. 1, Dienstmann, R. 2, Macarulla, T. 1
Zdroj: In Annals of Oncology 1 October 2016 27 Supplement 6:vi232-vi232
Databáze: ScienceDirect